Follow on Google News News By Tag Industry News * Pharmaceutical * More Industries... News By Location Country(s) Industry News
Follow on Google News | Anti-Malarials: Solutions for a Global ProblemMalaria is a global disease that half of the world's population is susceptible to. Not only does it present health but also economic consequences. AdvaCare endeavors to provide the medications and test kits in the fight to alleviate this epidemic.
So what is Malaria? It is a parasitic disease transmitted by Anopheles mosquitoes infected by the plasmodium parasites. These parasites lodge in the liver to mature and multiply. Within a month, 40,000 replications burst out infecting oxygen bearing red blood cells. What begins as flu-like symptoms could lead to life-threatening conditions such as brain damage, severe anemia, and kidney failure. Survivors are often left with permanent neurological damage. Various strains of the plasmodium parasite exist but the vast majority of deaths are caused by P. falciparum and P. vivax. AdvaCare’s AccuQuik range of medical test kits including Malaria Pf & Pv Antibody Rapid Test specifically target these 2 dangerous strains. This 1-step test kit is simple and reliable with accurate qualitative results obtainable in just 10 to 15 minutes. Produced according to ISO 13485 and ISO 9001 standards, they are available as strips or cassettes, and could also be manufactured under a client’s brand name and custom-packaged according to their specifications. Artemisinin based medications are the drug of choice amongst antimalarials. When paired with another antimalarial, it is known as Artemisinin- Increased malaria prevention and control measures have dramatically reduced this epidemic in many places. Malaria mortality rates have fallen by more than 25% globally since 2000 and by 33% in the WHO African Region. Early diagnosis and treatment of malaria reduces disease and prevents deaths. It also contributes to reducing transmission. Prevention, achievable through the spread of awareness and the adoption of measures such as sleeping under long-lasting insecticidal nets protects against malaria. To these ends, AdvaCare is a stakeholder in the fight against malaria. Four of AdvaCare’s antimalarials are featured in our March newsletter campaign. To be placed on this newsletter’s mailing list, please submit an email address under “Newsletter” End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|